YPO Global Pulse Survey: EU business confidence edges down from eight-year high
YPO chief executives in EU still optimistic about economic conditions; outlook in non-EU Europe down slightly in third quarter
LONDON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- YPO, the premier chief executive leadership organisation in the world, announced today that the YPO Global Pulse Confidence Index for the EU slipped 1.2 points to 61.8, down from its record level of 63.0 in the previous quarter, and slightly below the global composite score of 62.4.
The slight drop in EU confidence was mainly triggered by a more subdued outlook in three of the region's major economies, Germany, France and Spain. Germany declined 4.2 points to 58.5, and Spain slipped 4.3 points to 65.1, its lowest level since July 2016, and, following President Macron's victory in the general election, economic confidence in France fell 4.1 points to 60.6, reversing the 10.2-point rise in confidence it reported in the second quarter.
In other countries, there was little change in outlook. The United Kingdom remained steady with a score of 61.6, despite an apparent lack of progress in the ongoing Brexit negotiations. It was a similar story in Malta, which dropped less than one point to 64.8.
"It's probably no surprise that there is a slightly more cautious outlook in the EU, given the social and political uncertainty that is being experienced in some countries, such as the Catalan situation in Spain and the election results in Germany. However, despite this, chief executives in Europe remain positive about the strength of the economy and prospects for growth," said YPO member and President of Zenato, Nadia Zenato. "Business leaders will be looking for opportunities to expand as we move into 2018, while closely monitoring local and global economic performance indicators."
Non-EU Europe also saw a slight dip in confidence, dropping 1.7 points to 58.6. This was mainly due to a more subdued outlook in Switzerland, which fell 4.4 points to 57.5. This is against a background of the effects of a strong Swiss Franc on the Swiss export economy, as well as lackluster private and government consumption. On the other side of the scale, confidence in Turkey spiked 7 points. This coincides with stronger-than-expected economic growth in the country, and the International Monetary Fund (IMF) sharply increasing its GDP forecast for Turkey to 5.3% from 2.5% for 2017.
Overall, despite some localised headwinds and uncertainty around Brexit, both the EU and non-EU Europe remain firmly in positive territory.
Chief executives more cautious about short-term economic climate
Almost half (49%) of chief executives in the EU predicted that business and economic conditions would remain the same during the next six months, while 42% expected improved conditions, down from 46% in 2Q 2017, and 9% expected the economic environment to deteriorate.
Business leaders still confident about growth
When considering the prospects for their own organisations over the next 12 months, chief executives in the EU were firmly optimistic about the three key indicators of the YPO Global Pulse Survey, namely sales, employment and fixed investment.
Almost two-thirds (62%) of respondents expected to grow revenues, compared to only 2% who stated that their turnover would decline.
In terms of hiring, a third (33%) expected to increase headcount, while only 3% forecasted cuts to staff numbers.
Fixed investment outlook also remained buoyant, with almost half (48%) of respondents expecting to boost fixed investment levels, versus only 5% who predicted a reduction in investment spending.
Globally, confidence remained steady at 62.4, now firmly in positive territory for four consecutive surveys, hovering between 62.0 and 62.5. The United States was the most confident region at 63.5, Canadian confidence also remained positive, declining marginally by 1.1 points to 61.8, and Australasia saw a 3.7-point decline to 63.3. In Asia, confidence rose 1.3 points to 62.8, driven by an 8.8-point leap in China, and improved confidence in the Association of Southeast Asian Nations (ASEAN).
Elsewhere, confidence in Latin America jumped 2.8 points to 62.0, largely driven by Brazil's 8-point hike in confidence. In Africa, the confidence edged up 1.2 points to 57.5, yet it remains the second least-confident region, trailed only by the Middle East and North Africa (MENA) region, where confidence increased 2.5 points to 53.2.
YPO Global Pulse Confidence Index
The quarterly electronic survey, conducted in the first two weeks of October 2017, gathered answers from 925 chief executive officers across the globe, including 124 in the EU and 31 in non-EU Europe. Visit www.ypo.org/globalpulse for more information about the survey methodology and results from around the world.
The premier leadership organization of chief executives in the world.
YPO is the global platform for chief executives to engage, learn and grow. YPO members harness the knowledge, influence and trust of the world's most influential and innovative business leaders to inspire business, personal, family and community impact.
Today, YPO empowers more than 25,000 members in more than 130 countries, diversified among industries and types of businesses. Altogether, YPO member-run companies employ more than 16 million people and generate USD6 trillion in annual revenues.
Office: +1 972 629 7305 (United States)
Mobile: +1 972 207 4298
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YPO via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45 | Pressemelding
CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH
Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30 | Pressemelding
(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional
Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16 | Pressemelding
London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h
SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00 | Pressemelding
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00 | Pressemelding
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow
PRA Named International Clinical Research Company of the Year24.5.2018 10:00 | Pressemelding
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom